The most common cause of viral resistance, reduced effectiveness, and therapeutic failure with antiretroviral therapy (ART) is nonadherence to the recommended drug regimen. Full adherence to most medications requires that patients take 95% of their dose at the recommended times. Yet studies find various rates of non-adherence or sub-optimal use ranging from 17% to as high as 95%. In HIV treatment, adherence rates as low as 50% contribute to viral resistance and reduce the protective effects … [Read more...]
We All Have Important Roles to Play: National Black HIV/AIDS Awareness Day – February 7, 2011
February 3, 2011 by
As we approach the 11th annual observance of National Black HIV/AIDS Awareness Day (NBHAAD) on February 7th, we are reminded that the impact of HIV is greater among Blacks than any other racial/ethnic group in the United States. African Americans represent 13 percent of the U.S. population; but 46 percent of the estimated 1.1 million people living with HIV in the United States are Black (that’s more than 500,000 African Americans living with HIV in the U.S. today). For more information … [Read more...]
